Semaglutide doesn’t produce the same results for everyone, and a number of common factors can slow or stall weight loss even when you’re taking it consistently. In clinical trials, participants lost an average of 15% of their body weight over about 68 weeks, but individual results ranged widely, from over 20% to a modest 5 to 10%. If you’re on the lower end or seeing no movement at all, there are specific reasons worth investigating.
You May Still Be on a Starter Dose
Semaglutide is prescribed with a gradual dose increase, and the early doses aren’t designed to produce significant weight loss. You start at 0.25 mg weekly for the first four weeks just to let your body adjust. At week five, the dose increases to 0.5 mg. For weight management specifically (the brand name Wegovy), the dose continues climbing over several months until reaching a maintenance dose of 1.7 mg or the recommended 2.4 mg weekly.
If you’re still in the first two or three months, you likely haven’t reached a therapeutic dose yet. The STEP 1 trial showed participants on the full 2.4 mg dose lost about 3.8% of body weight after just four weeks and 9.6% after 12 weeks. The real momentum builds over time. Expecting dramatic changes during titration sets you up for unnecessary frustration.
Your Calorie Intake May Still Be Too High
Semaglutide reduces appetite, but it doesn’t guarantee a calorie deficit. Many people find that their hunger returns partially as they adjust to each dose, or they continue eating calorie-dense foods in smaller portions that still add up. Liquid calories from alcohol, sugary drinks, or coffee drinks are easy to overlook. So are oils, sauces, and snacks that don’t register as full meals.
As you lose weight, your calorie needs drop. Someone who has lost 30 pounds, for example, needs roughly 200 to 300 fewer daily calories than they did before the weight loss. If you’re eating the same amount you were at the start of treatment, you may have gradually erased your deficit without realizing it. Tracking your intake for even a week or two can reveal patterns that are hard to spot otherwise.
Muscle Loss Is Slowing Your Metabolism
This is one of the less obvious reasons weight loss stalls on semaglutide, and it’s more significant than many people realize. In the STEP 1 trial, participants who lost an average of 15.3 kg saw about 6.9 kg of that come from lean mass, meaning roughly 45% of the weight lost was muscle and other non-fat tissue. That’s considerably higher than the general expectation that about one-quarter of weight loss comes from lean tissue.
Muscle is metabolically active. It burns calories at rest. When you lose a large proportion of muscle along with fat, your resting metabolic rate drops faster than it would from fat loss alone. This creates a shrinking calorie deficit even if your eating habits haven’t changed. The result is a plateau that feels like the medication stopped working, when in reality your body simply needs fewer calories than it did weeks ago.
Resistance training is the most effective way to counteract this. Lifting weights, using resistance bands, or doing bodyweight exercises two to three times per week sends a signal to your body to preserve muscle. Protein intake matters here too: higher-protein diets have been shown to enhance weight loss by as much as 30%, partly because protein helps maintain muscle mass during a calorie deficit. Prioritizing chicken, fish, beans, eggs, and legumes at every meal makes a measurable difference.
Underlying Conditions Can Slow Progress
Certain metabolic conditions change how your body responds to semaglutide. Polycystic ovary syndrome (PCOS) and insulin resistance are among the most common. A pilot study of 20 women with PCOS and obesity found that semaglutide combined with metformin did produce significant weight loss over five months, dropping from an average of 98.4 kg to 85.5 kg, with meaningful fat mass reduction. But the doses used were lower (0.25 to 0.5 mg weekly), and the timeline was longer than what many people without these conditions experience.
Thyroid disorders, particularly an underactive thyroid, can also blunt weight loss. Sleep apnea, chronic stress, and medications like certain antidepressants, beta-blockers, or steroids all promote weight retention through different mechanisms. If you have any of these conditions or take medications that affect weight, your trajectory on semaglutide will look different from the averages reported in clinical trials. That doesn’t mean the medication isn’t working. It means the baseline your body is working against is harder to move.
Your Body Has Hit a Set Point Plateau
Plateaus are a normal part of weight loss on any treatment, including semaglutide. After losing a significant amount of weight, your body actively resists further loss. Levels of hormones that drive hunger increase while hormones that signal fullness decrease. Your metabolism becomes more efficient, burning fewer calories for the same activities. This isn’t a failure of the medication. It’s your body’s built-in survival response to sustained weight loss.
Most people experience their first noticeable plateau somewhere between three and six months. At the six-month mark in the STEP 1 trial, average weight loss was 13.8%, and the pace slowed considerably after that, reaching about 15% by 68 weeks. The bulk of the loss happens in the first six months, with the following months focused more on maintaining and slowly adding to those results.
Breaking through a plateau typically requires changing something: adjusting your calorie target downward, increasing physical activity, adding resistance training if you haven’t already, or discussing a dose adjustment with your prescriber. Sometimes the answer is simply patience. A plateau lasting two to four weeks is common and often resolves on its own.
Consistency and Injection Timing Matter
Semaglutide works best when taken on a consistent schedule. Missing doses, taking them late, or accidentally injecting into muscle rather than fat can all affect how the medication performs. The injection should go into subcutaneous fat, typically in the abdomen, thigh, or upper arm. Some evidence suggests abdominal injections may absorb slightly faster than thigh injections, though the difference is small.
More importantly, rotating your injection site prevents the fat tissue from developing lumps or scar tissue that could interfere with absorption over time. If you’ve been injecting in the exact same spot every week, switching to a different area within the same region can help.
What Realistic Progress Looks Like
It helps to recalibrate expectations. On the full maintenance dose with lifestyle changes, the average trajectory looks roughly like this: about 4% of body weight lost in the first month, close to 10% by three months, around 14% by six months, and 15 to 17% by one year. For someone starting at 220 pounds, that’s about 9 pounds in the first month, 22 pounds by three months, and 33 to 37 pounds by a year.
But these are averages. Some people lose more than 20% of their starting weight. Others land closer to 5 to 10%. Both outcomes fall within the normal range of response. If you’re losing weight at all, even slowly, the medication is doing its job. The question is whether lifestyle factors, dose, or an underlying condition is limiting how much further you can go. Addressing those factors one at a time is more productive than assuming the drug isn’t working.